PL3592734T3 - Sól aminowa kwasu (1r,3s)-3-(5-cyano-4-fenylo-1,3-tiazol- 2-ilokarbamoilo)cyklopentanokarboksylowego - Google Patents
Sól aminowa kwasu (1r,3s)-3-(5-cyano-4-fenylo-1,3-tiazol- 2-ilokarbamoilo)cyklopentanokarboksylowegoInfo
- Publication number
- PL3592734T3 PL3592734T3 PL18710011T PL18710011T PL3592734T3 PL 3592734 T3 PL3592734 T3 PL 3592734T3 PL 18710011 T PL18710011 T PL 18710011T PL 18710011 T PL18710011 T PL 18710011T PL 3592734 T3 PL3592734 T3 PL 3592734T3
- Authority
- PL
- Poland
- Prior art keywords
- ylcarbamoyl
- thiazol
- cyano
- phenyl
- carboxylic acid
- Prior art date
Links
- MSZKZEFOAPULKG-NWDGAFQWSA-N (1r,3s)-3-[(5-cyano-4-phenyl-1,3-thiazol-2-yl)carbamoyl]cyclopentane-1-carboxylic acid Chemical compound C1[C@H](C(=O)O)CC[C@@H]1C(=O)NC1=NC(C=2C=CC=CC=2)=C(C#N)S1 MSZKZEFOAPULKG-NWDGAFQWSA-N 0.000 title 1
- -1 Amine salt Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17382114 | 2017-03-06 | ||
| PCT/EP2018/055512 WO2018162505A1 (en) | 2017-03-06 | 2018-03-06 | Amine salt of (1r,3s)-3-(5-cyano-4-phenyl-1,3-thiazol-2-ylcarbamoyl)cyclopentane carboxylic acid |
| EP18710011.0A EP3592734B1 (en) | 2017-03-06 | 2018-03-06 | Amine salt of (1r,3s)-3-(5-cyano-4-phenyl-1,3-thiazol-2-ylcarbamoyl)cyclopentane carboxylic acid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3592734T3 true PL3592734T3 (pl) | 2021-11-02 |
Family
ID=58266535
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL18710011T PL3592734T3 (pl) | 2017-03-06 | 2018-03-06 | Sól aminowa kwasu (1r,3s)-3-(5-cyano-4-fenylo-1,3-tiazol- 2-ilokarbamoilo)cyklopentanokarboksylowego |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US10583127B2 (pl) |
| EP (1) | EP3592734B1 (pl) |
| JP (1) | JP6827124B2 (pl) |
| CY (1) | CY1124442T1 (pl) |
| DK (1) | DK3592734T3 (pl) |
| ES (1) | ES2881777T3 (pl) |
| HR (1) | HRP20211104T1 (pl) |
| HU (1) | HUE055259T2 (pl) |
| LT (1) | LT3592734T (pl) |
| PL (1) | PL3592734T3 (pl) |
| PT (1) | PT3592734T (pl) |
| RS (1) | RS62089B1 (pl) |
| SI (1) | SI3592734T1 (pl) |
| SM (1) | SMT202100419T1 (pl) |
| WO (1) | WO2018162505A1 (pl) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3882240A1 (en) * | 2020-03-16 | 2021-09-22 | Palobiofarma, S.L. | Cocrystals of (1r,3s)-3-(5-cyano-4-phenyl-1,3-thiazol-2-ylcabamoyl)cyclopentane carboxylic acid |
| EP3957308A1 (en) * | 2020-08-21 | 2022-02-23 | Palobiofarma, S.L. | (1r,3s)-3-((5-cyano-4-phenylthiazol-2-yl)carbamoyl)cyclopentane-1-carboxylic acid and derivatives thereof for use in the treatment of airway diseases |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2331220B1 (es) | 2007-10-02 | 2010-09-23 | Palobiofarma, S.L. | Nuevos compuestos como antagonistas de los receptores a1 de adenosina. |
| UA109287C2 (uk) * | 2010-11-02 | 2015-08-10 | Солі органічного аміну похідних амінобензойної кислоти і спосіб їх одержання | |
| US9688682B2 (en) * | 2013-07-16 | 2017-06-27 | Dr. Reddy's Laboratories Limited | Crystalline forms of pemetrexed tromethamine salts |
-
2018
- 2018-03-06 PT PT187100110T patent/PT3592734T/pt unknown
- 2018-03-06 EP EP18710011.0A patent/EP3592734B1/en active Active
- 2018-03-06 WO PCT/EP2018/055512 patent/WO2018162505A1/en not_active Ceased
- 2018-03-06 RS RS20210814A patent/RS62089B1/sr unknown
- 2018-03-06 JP JP2019548479A patent/JP6827124B2/ja active Active
- 2018-03-06 SM SM20210419T patent/SMT202100419T1/it unknown
- 2018-03-06 PL PL18710011T patent/PL3592734T3/pl unknown
- 2018-03-06 ES ES18710011T patent/ES2881777T3/es active Active
- 2018-03-06 HU HUE18710011A patent/HUE055259T2/hu unknown
- 2018-03-06 US US16/491,185 patent/US10583127B2/en active Active
- 2018-03-06 LT LTEP18710011.0T patent/LT3592734T/lt unknown
- 2018-03-06 DK DK18710011.0T patent/DK3592734T3/da active
- 2018-03-06 SI SI201830323T patent/SI3592734T1/sl unknown
- 2018-03-06 HR HRP20211104TT patent/HRP20211104T1/hr unknown
-
2021
- 2021-07-09 CY CY20211100621T patent/CY1124442T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP6827124B2 (ja) | 2021-02-10 |
| WO2018162505A1 (en) | 2018-09-13 |
| EP3592734A1 (en) | 2020-01-15 |
| HUE055259T2 (hu) | 2021-11-29 |
| EP3592734B1 (en) | 2021-05-19 |
| LT3592734T (lt) | 2021-07-26 |
| RS62089B1 (sr) | 2021-08-31 |
| ES2881777T3 (es) | 2021-11-30 |
| JP2020509066A (ja) | 2020-03-26 |
| HRP20211104T1 (hr) | 2021-10-15 |
| SI3592734T1 (sl) | 2021-08-31 |
| PT3592734T (pt) | 2021-07-21 |
| US10583127B2 (en) | 2020-03-10 |
| US20200030300A1 (en) | 2020-01-30 |
| DK3592734T3 (da) | 2021-06-28 |
| CY1124442T1 (el) | 2022-07-22 |
| SMT202100419T1 (it) | 2021-09-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL280856A (en) | 3-Alkyl-4-amino-[0,5,4] bicyclic hydroxamic acids as HDAC inhibitors | |
| ZA201808100B (en) | Cyclopropyl-amide compounds as dual lsd1/hdac inhibitors | |
| EP3145420A4 (en) | Intra operative tracking method | |
| PH12017501523A1 (en) | Selective bace1 inhibitors | |
| HUE059670T2 (hu) | Eljárás új nitrogén-tartalmú vegyület vagy sója és intermedierjei elõállítására | |
| NZ722412A (en) | Methods of preparing a hydrochloride salt of (1r,2r,5r)-5-amino-2-methylcyclohexanol | |
| EP3093605A4 (en) | Shell-and-tube welding method | |
| SI3592734T1 (sl) | Aminska sol (1R,3S)-3-(5-ciano-4-fenil-1,3-tiazol-2-ilkarbamoil)ciklopentan karboksilne kisline | |
| TW201713618A (en) | Cyclopropane carboxylic acid amide compound and herbicide containing same | |
| IL258320B (en) | Method for synthesizing n-(1,3,4-oxadiazole-2-yl)aryl carboxamides | |
| EP3167874A4 (en) | Universal cardioplegic solution (variants) | |
| EP3318550A4 (en) | Method for preparing benzoic acid amide compound | |
| EP3279199A4 (en) | Non-deliquescent acid addition salt of 3-aminoquinuclidine | |
| GB201719127D0 (en) | Methylchloroperoxybenzoic acid drug intermediates synthesis method | |
| EP3205641A4 (en) | Aqueous solution containing bis(n -lauroyllysine)dicarboxylic acid diamide and/or salt thereof, and method for producing same | |
| EP3279184A4 (en) | Novel benzoic acid amide compound | |
| GB201715085D0 (en) | 2-furanacrylic acid drug intermediates synthesis method | |
| GB201715112D0 (en) | P-methoxphenylacetic acid drug intermediates synthesis method | |
| GB201714451D0 (en) | 3-methoxy-4-hydroxy-5-nitrobenzoic acid drug intermediates synthesis method | |
| GB201709978D0 (en) | Drug intermediates p-benzoylbenzoic acid synthesis method | |
| GB201708124D0 (en) | Isopropyl myristate drug intermediates myristic acid synthesis method | |
| HK40005421A (en) | Inhibitors of alpha-amino-beta-carboxymuconic acid semialdehyde decarboxylase | |
| GB201719123D0 (en) | 2,3-dihydroxy-succinic acid drug intermediates synthesis method | |
| GB201714450D0 (en) | 4,6-dihydroxyquinoline-5,8-diquinone-2-formic acid drug intermediates synthesis method | |
| GB201705531D0 (en) | Pyranzinamide drug intermediates p-diazabenzene-2,3-dicarboxylic acid synthesis method |